Neuren Pharmaceuticals reports US$125M quarterly sales
Neuren Pharmaceuticals (ASX:NEU) reported second-quarter DAYBUE net sales of US$125 million through partner Acadia Pharmaceuticals (NASDAQ:ACAD).

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Neuren Pharmaceuticals (ASX:NEU) reported second-quarter DAYBUE net sales of US$125 million through partner Acadia Pharmaceuticals (NASDAQ:ACAD).
India expanded tax reporting rules to cover crypto assets and central bank digital currencies, with the changes starting 1 April 2027.
EQ Resources (ASX:EQR) generated revenue of $51 million in July after output rose 36%.
Tether Gold (CRYPTO:XAUT) physical reserves increased 9.5% in Q2 as demand continued despite falling gold prices.
Zen Energy entered administration after failing to manage significant downside risk across its long-term electricity contracts.
Qnity Electronics (NYSE:Q) reported second-quarter net sales of $1.429 billion, up 22%, while adjusted operating EBITDA reached $431 million.
Enpro (NYSE:NPO) reported second-quarter sales of $338.8 million, up 17.6%, as both operating segments recorded double-digit growth.
Caterpillar (NYSE:CAT) reported second-quarter sales and revenues of $20.5 billion, up 24%, marking its first quarter above $20 billion.
Ingredion Incorporated (NYSE:INGR) reported second-quarter net sales of $1.85 billion, up 1%, while adjusted operating income fell 5% to $258 million.
DuPont (NYSE:DD) reported second-quarter net sales of $1.819 billion, up 4%, while adjusted EPS rose 48% to $1.88.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy